Suppr超能文献

正确折叠的人谷氨酸脱羧酶65作为融合蛋白在大肠杆菌中的表达。

Expression of properly folded human glutamate decarboxylase 65 as a fusion protein in Escherichia coli.

作者信息

Papouchado M L, Valdez S N, Ghiringhelli D, Poskus E, Ermácora M R

机构信息

Cátedra de Immunología, Facultad de Farmacia y Bioquimica, Universidadde Buenos Aires, Argentina.

出版信息

Eur J Biochem. 1997 Jun 1;246(2):350-9. doi: 10.1111/j.1432-1033.1997.00350.x.

Abstract

Autoantibodies to the islet-cell 65-kDa variant of glutamate decarboxylase (GAD65) are found in most insulin-dependent diabetes mellitus (IDDM) patients many years before the appearance of clinical symptoms of the disease. As IDDM-preventive therapies may be available in the future, an international effort is taking place to develop widely applicable anti-GAD immunochemical tests. These tests would help to detect individuals at risk before the full installation of the disease and to enroll them in prevention programs. Autoantibodies to GAD65 are mostly directed to conformational epitopes, and the enzyme is a complex molecule with a prosthetic group and 15 cysteine residues. Thus, the conformational integrity of GAD65 is essential for an appropriate anti-GAD assay. Isolation of large amounts of GAD65 from pancreas or other tissues is impractical, and no successful production of properly folded GAD65 has been reported in bacteria. Native recombinant GAD65 for immunochemical tests is usually obtained from eukaryotic expression systems. Since the large-scale production of a recombinant protein in an eukaryotic system is expensive and technically difficult, we investigated the expression of GAD65 in Escherichia coli as an alternative. A number of DNA constructs intended to export the enzyme to the periplasmic space or to improve its cytoplasmic solubility were designed and tested. Our results provide a solution to the two main problems associated with the expression of GAD65 in E. coli: misfolding, leading to the formation of inclusion bodies; and the presence of alternative initiation sites for translation that causes the preferential production of truncated variants of GAD65. We describe here the production of properly folded, fully active, and immunochemically competent GAD65 as an N-terminal fusion protein with thioredoxin. An account of the reactivity of the produced protein with sera of six IDDM patients is also presented.

摘要

在大多数胰岛素依赖型糖尿病(IDDM)患者出现临床症状的许多年前,就可检测到针对胰岛细胞中65 kDa谷氨酸脱羧酶(GAD65)变体的自身抗体。鉴于未来可能会有IDDM预防疗法,国际上正在努力开发广泛适用的抗GAD免疫化学检测方法。这些检测方法将有助于在疾病完全发作之前检测出有患病风险的个体,并使他们能够参与预防计划。针对GAD65的自身抗体大多针对构象表位,该酶是一种带有辅基和15个半胱氨酸残基的复杂分子。因此,GAD65的构象完整性对于合适的抗GAD检测至关重要。从胰腺或其他组织中大量分离GAD65是不切实际的,并且尚未有在细菌中成功生产出正确折叠的GAD65的报道。用于免疫化学检测的天然重组GAD65通常从真核表达系统中获得。由于在真核系统中大规模生产重组蛋白成本高昂且技术难度大,我们研究了在大肠杆菌中表达GAD65作为替代方法。设计并测试了许多旨在将该酶输出到周质空间或提高其胞质溶解度的DNA构建体。我们的结果为与GAD65在大肠杆菌中表达相关的两个主要问题提供了解决方案:错误折叠导致包涵体形成;以及存在导致优先产生GAD65截短变体的翻译起始替代位点。我们在此描述了作为与硫氧还蛋白的N端融合蛋白产生正确折叠、具有完全活性且具有免疫化学活性的GAD65。还介绍了所产生的蛋白与六名IDDM患者血清反应性的情况。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验